Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus

Aileen Sy, Stephen D. McLeod, Elisabeth J. Cohen, Todd P. Margolis, Mark J Mannis, Thomas M. Lietman, Nisha R. Acharya

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

PURPOSE: The objective of this study was to determine current practices and opinions among cornea specialists for treating and preventing recurrences of herpes zoster ophthalmicus (HZO). METHODS: In November 2010, a survey of 15 questions was distributed to The Cornea Society listserv. Questions identified respondents' treatment practices for recurrent HZO and opinions regarding prolonged antiviral prophylaxis and zoster vaccine. RESULTS: Of 100 respondents, the majority were cornea specialists (83 of 98, 85%). Eighty-seven percent (84 of 97) reported treating recurrent or chronic cases of HZO in the last year. The most common choice of treatment in the posed recurrent HZO clinical scenario was a combination of oral antiviral and topical corticosteroid (63 of 100, 63%), although significant variability existed in the duration of oral antiviral administration. Fifty-four respondents (56%) believed that prolonged acyclovir prophylaxis could reduce recurrent signs of HZO; 28% (27 of 98) believed that recurrences of HZO could be reduced after the period of acyclovir administration. For patients with a history of HZO, most respondents reported not recommending the adult zoster vaccine (63 of 98, 64%), but 46% (43 of 94) believed that the vaccine could reduce recurrent signs or did not know. CONCLUSIONS: Many cornea specialists are managing recurrent or chronic cases of HZO, but there is variability in the use of topical corticosteroids and antivirals. Additionally, no consensus exists on the efficacy of prolonged antiviral therapy or the adult zoster vaccine to reduce chronic or recurrent disease. These results demonstrate the need for further systematic study of treatment and prophylaxis for recurrent and chronic HZO.

Original languageEnglish (US)
Pages (from-to)786-790
Number of pages5
JournalCornea
Volume31
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Herpes Zoster Ophthalmicus
Herpes Zoster Vaccine
Antiviral Agents
Cornea
Acyclovir
Adrenal Cortex Hormones
Recurrence
Therapeutics
Oral Administration
Vaccines
Surveys and Questionnaires

Keywords

  • herpes zoster ophthalmicus
  • management
  • practice patterns
  • recurrence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Sy, A., McLeod, S. D., Cohen, E. J., Margolis, T. P., Mannis, M. J., Lietman, T. M., & Acharya, N. R. (2012). Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea, 31(7), 786-790. https://doi.org/10.1097/ICO.0b013e31823cbe6a

Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. / Sy, Aileen; McLeod, Stephen D.; Cohen, Elisabeth J.; Margolis, Todd P.; Mannis, Mark J; Lietman, Thomas M.; Acharya, Nisha R.

In: Cornea, Vol. 31, No. 7, 07.2012, p. 786-790.

Research output: Contribution to journalArticle

Sy, A, McLeod, SD, Cohen, EJ, Margolis, TP, Mannis, MJ, Lietman, TM & Acharya, NR 2012, 'Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus', Cornea, vol. 31, no. 7, pp. 786-790. https://doi.org/10.1097/ICO.0b013e31823cbe6a
Sy, Aileen ; McLeod, Stephen D. ; Cohen, Elisabeth J. ; Margolis, Todd P. ; Mannis, Mark J ; Lietman, Thomas M. ; Acharya, Nisha R. / Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. In: Cornea. 2012 ; Vol. 31, No. 7. pp. 786-790.
@article{1af9074e56b84c10b4a8da9e62d61af0,
title = "Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus",
abstract = "PURPOSE: The objective of this study was to determine current practices and opinions among cornea specialists for treating and preventing recurrences of herpes zoster ophthalmicus (HZO). METHODS: In November 2010, a survey of 15 questions was distributed to The Cornea Society listserv. Questions identified respondents' treatment practices for recurrent HZO and opinions regarding prolonged antiviral prophylaxis and zoster vaccine. RESULTS: Of 100 respondents, the majority were cornea specialists (83 of 98, 85{\%}). Eighty-seven percent (84 of 97) reported treating recurrent or chronic cases of HZO in the last year. The most common choice of treatment in the posed recurrent HZO clinical scenario was a combination of oral antiviral and topical corticosteroid (63 of 100, 63{\%}), although significant variability existed in the duration of oral antiviral administration. Fifty-four respondents (56{\%}) believed that prolonged acyclovir prophylaxis could reduce recurrent signs of HZO; 28{\%} (27 of 98) believed that recurrences of HZO could be reduced after the period of acyclovir administration. For patients with a history of HZO, most respondents reported not recommending the adult zoster vaccine (63 of 98, 64{\%}), but 46{\%} (43 of 94) believed that the vaccine could reduce recurrent signs or did not know. CONCLUSIONS: Many cornea specialists are managing recurrent or chronic cases of HZO, but there is variability in the use of topical corticosteroids and antivirals. Additionally, no consensus exists on the efficacy of prolonged antiviral therapy or the adult zoster vaccine to reduce chronic or recurrent disease. These results demonstrate the need for further systematic study of treatment and prophylaxis for recurrent and chronic HZO.",
keywords = "herpes zoster ophthalmicus, management, practice patterns, recurrence",
author = "Aileen Sy and McLeod, {Stephen D.} and Cohen, {Elisabeth J.} and Margolis, {Todd P.} and Mannis, {Mark J} and Lietman, {Thomas M.} and Acharya, {Nisha R.}",
year = "2012",
month = "7",
doi = "10.1097/ICO.0b013e31823cbe6a",
language = "English (US)",
volume = "31",
pages = "786--790",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus

AU - Sy, Aileen

AU - McLeod, Stephen D.

AU - Cohen, Elisabeth J.

AU - Margolis, Todd P.

AU - Mannis, Mark J

AU - Lietman, Thomas M.

AU - Acharya, Nisha R.

PY - 2012/7

Y1 - 2012/7

N2 - PURPOSE: The objective of this study was to determine current practices and opinions among cornea specialists for treating and preventing recurrences of herpes zoster ophthalmicus (HZO). METHODS: In November 2010, a survey of 15 questions was distributed to The Cornea Society listserv. Questions identified respondents' treatment practices for recurrent HZO and opinions regarding prolonged antiviral prophylaxis and zoster vaccine. RESULTS: Of 100 respondents, the majority were cornea specialists (83 of 98, 85%). Eighty-seven percent (84 of 97) reported treating recurrent or chronic cases of HZO in the last year. The most common choice of treatment in the posed recurrent HZO clinical scenario was a combination of oral antiviral and topical corticosteroid (63 of 100, 63%), although significant variability existed in the duration of oral antiviral administration. Fifty-four respondents (56%) believed that prolonged acyclovir prophylaxis could reduce recurrent signs of HZO; 28% (27 of 98) believed that recurrences of HZO could be reduced after the period of acyclovir administration. For patients with a history of HZO, most respondents reported not recommending the adult zoster vaccine (63 of 98, 64%), but 46% (43 of 94) believed that the vaccine could reduce recurrent signs or did not know. CONCLUSIONS: Many cornea specialists are managing recurrent or chronic cases of HZO, but there is variability in the use of topical corticosteroids and antivirals. Additionally, no consensus exists on the efficacy of prolonged antiviral therapy or the adult zoster vaccine to reduce chronic or recurrent disease. These results demonstrate the need for further systematic study of treatment and prophylaxis for recurrent and chronic HZO.

AB - PURPOSE: The objective of this study was to determine current practices and opinions among cornea specialists for treating and preventing recurrences of herpes zoster ophthalmicus (HZO). METHODS: In November 2010, a survey of 15 questions was distributed to The Cornea Society listserv. Questions identified respondents' treatment practices for recurrent HZO and opinions regarding prolonged antiviral prophylaxis and zoster vaccine. RESULTS: Of 100 respondents, the majority were cornea specialists (83 of 98, 85%). Eighty-seven percent (84 of 97) reported treating recurrent or chronic cases of HZO in the last year. The most common choice of treatment in the posed recurrent HZO clinical scenario was a combination of oral antiviral and topical corticosteroid (63 of 100, 63%), although significant variability existed in the duration of oral antiviral administration. Fifty-four respondents (56%) believed that prolonged acyclovir prophylaxis could reduce recurrent signs of HZO; 28% (27 of 98) believed that recurrences of HZO could be reduced after the period of acyclovir administration. For patients with a history of HZO, most respondents reported not recommending the adult zoster vaccine (63 of 98, 64%), but 46% (43 of 94) believed that the vaccine could reduce recurrent signs or did not know. CONCLUSIONS: Many cornea specialists are managing recurrent or chronic cases of HZO, but there is variability in the use of topical corticosteroids and antivirals. Additionally, no consensus exists on the efficacy of prolonged antiviral therapy or the adult zoster vaccine to reduce chronic or recurrent disease. These results demonstrate the need for further systematic study of treatment and prophylaxis for recurrent and chronic HZO.

KW - herpes zoster ophthalmicus

KW - management

KW - practice patterns

KW - recurrence

UR - http://www.scopus.com/inward/record.url?scp=84862878974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862878974&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e31823cbe6a

DO - 10.1097/ICO.0b013e31823cbe6a

M3 - Article

C2 - 22269677

AN - SCOPUS:84862878974

VL - 31

SP - 786

EP - 790

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 7

ER -